NDC properties for "Tobrex 0.003 MG/MG Ophthalmic Ointment" (RxCUI 207850)
About this data
The tables show NDC propoerties for Tobrex 0.003 MG/MG Ophthalmic Ointment with the RxCUI 207850
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Tobrex 0.003 MG/MG Ophthalmic Ointment (RxCUI 207850)
MMSL_CODE | BD2822 |
---|---|
NDA | NDA050555 |
RxCUI | 207850 |
SPL_SET_ID | 3d4be22b-7a8c-4247-ac35-143611342de1 |
SPL_SET_ID | 5b66bba3-cf97-4a9c-b618-ba5f277f20f6 |
SPL_SET_ID | b1d58360-96b4-4d23-82aa-3e4872dc0136 |
Prescribable Synonym | Tobrex 0.3 % Ophthalmic Ointment |
RXNAV_STR | Tobrex 0.3 % Ophthalmic Ointment |
RxNorm Name | tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobrex] |
RxNorm Synonym | Tobrex 0.003 MG/MG Ophthalmic Ointment |
RxNorm Synonym | Tobrex 0.3 % Ophthalmic Ointment |
Related queries | Interactions (for RxCUI 207850) |
NDC Properties
NDC Item 00065064435
NDC 9 | 0065-0644 |
---|---|
NDC 10 | 0065-0644-35 |
NDC Item | 00065064435 |
Packaging | 3.5 g in 1 TUBE (0065-0644-35) |
FDA SPL set id | 691162 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-07-31 |
Marketing effective time low | 1981-06-28 |
Marketing status | COMPLETED |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0065-0644 |
NDC Item 00078081301
NDC 9 | 0078-0813 |
---|---|
NDC 10 | 0078-0813-01 |
NDC Item | 00078081301 |
Packaging | 3.5 g in 1 TUBE (0078-0813-01) |
FDA SPL set id | 861855 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1981-06-28 |
Marketing status | ACTIVE |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0078-0813 |
NDC Item 00247088181
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00247088181 |
Related queries | Properties for NDC 9 |
NDC Item 49999025935
NDC 9 | 49999-259 |
---|---|
NDC 10 | 49999-259-35 |
NDC Item | 49999025935 |
Related queries | Properties for NDC 9 49999-259 |
NDC Item 52959005101
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005101 |
Related queries | Properties for NDC 9 |
NDC Item 52959005103
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005103 |
Related queries | Properties for NDC 9 |
NDC Item 68071133505
NDC 9 | 68071-1335 |
---|---|
NDC 10 | 68071-1335-5 |
NDC Item | 68071133505 |
Related queries | Properties for NDC 9 68071-1335 |
NDC Item 00065064435
NDC 9 | 0065-0644 |
---|---|
NDC 10 | 0065-0644-35 |
NDC Item | 00065064435 |
Packaging | 3.5 g in 1 TUBE (0065-0644-35) |
FDA SPL set id | 691162 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-07-31 |
Marketing effective time low | 1981-06-28 |
Marketing status | COMPLETED |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0065-0644 |
NDC Item 00078081301
NDC 9 | 0078-0813 |
---|---|
NDC 10 | 0078-0813-01 |
NDC Item | 00078081301 |
Packaging | 3.5 g in 1 TUBE (0078-0813-01) |
FDA SPL set id | 861855 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1981-06-28 |
Marketing status | ACTIVE |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0078-0813 |
NDC Item 00247088181
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00247088181 |
Related queries | Properties for NDC 9 |
NDC Item 49999025935
NDC 9 | 49999-259 |
---|---|
NDC 10 | 49999-259-35 |
NDC Item | 49999025935 |
Related queries | Properties for NDC 9 49999-259 |
NDC Item 52959005101
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005101 |
Related queries | Properties for NDC 9 |
NDC Item 52959005103
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005103 |
Related queries | Properties for NDC 9 |
NDC Item 68071133505
NDC 9 | 68071-1335 |
---|---|
NDC 10 | 68071-1335-5 |
NDC Item | 68071133505 |
Related queries | Properties for NDC 9 68071-1335 |
NDC Item 00065064435
NDC 9 | 0065-0644 |
---|---|
NDC 10 | 0065-0644-35 |
NDC Item | 00065064435 |
Packaging | 3.5 g in 1 TUBE (0065-0644-35) |
FDA SPL set id | 691162 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-07-31 |
Marketing effective time low | 1981-06-28 |
Marketing status | COMPLETED |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0065-0644 |
NDC Item 00078081301
NDC 9 | 0078-0813 |
---|---|
NDC 10 | 0078-0813-01 |
NDC Item | 00078081301 |
Packaging | 3.5 g in 1 TUBE (0078-0813-01) |
FDA SPL set id | 861855 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1981-06-28 |
Marketing status | ACTIVE |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0078-0813 |
NDC Item 00247088181
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00247088181 |
Related queries | Properties for NDC 9 |
NDC Item 49999025935
NDC 9 | 49999-259 |
---|---|
NDC 10 | 49999-259-35 |
NDC Item | 49999025935 |
Related queries | Properties for NDC 9 49999-259 |
NDC Item 52959005101
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005101 |
Related queries | Properties for NDC 9 |
NDC Item 52959005103
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005103 |
Related queries | Properties for NDC 9 |
NDC Item 68071133505
NDC 9 | 68071-1335 |
---|---|
NDC 10 | 68071-1335-5 |
NDC Item | 68071133505 |
Related queries | Properties for NDC 9 68071-1335 |
NDC Item 00065064435
NDC 9 | 0065-0644 |
---|---|
NDC 10 | 0065-0644-35 |
NDC Item | 00065064435 |
Packaging | 3.5 g in 1 TUBE (0065-0644-35) |
FDA SPL set id | 691162 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-07-31 |
Marketing effective time low | 1981-06-28 |
Marketing status | COMPLETED |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0065-0644 |
NDC Item 00078081301
NDC 9 | 0078-0813 |
---|---|
NDC 10 | 0078-0813-01 |
NDC Item | 00078081301 |
Packaging | 3.5 g in 1 TUBE (0078-0813-01) |
FDA SPL set id | 861855 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1981-06-28 |
Marketing status | ACTIVE |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0078-0813 |
NDC Item 00247088181
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00247088181 |
Related queries | Properties for NDC 9 |
NDC Item 49999025935
NDC 9 | 49999-259 |
---|---|
NDC 10 | 49999-259-35 |
NDC Item | 49999025935 |
Related queries | Properties for NDC 9 49999-259 |
NDC Item 52959005101
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005101 |
Related queries | Properties for NDC 9 |
NDC Item 52959005103
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005103 |
Related queries | Properties for NDC 9 |
NDC Item 68071133505
NDC 9 | 68071-1335 |
---|---|
NDC 10 | 68071-1335-5 |
NDC Item | 68071133505 |
Related queries | Properties for NDC 9 68071-1335 |
NDC Item 00065064435
NDC 9 | 0065-0644 |
---|---|
NDC 10 | 0065-0644-35 |
NDC Item | 00065064435 |
Packaging | 3.5 g in 1 TUBE (0065-0644-35) |
FDA SPL set id | 691162 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-07-31 |
Marketing effective time low | 1981-06-28 |
Marketing status | COMPLETED |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0065-0644 |
NDC Item 00078081301
NDC 9 | 0078-0813 |
---|---|
NDC 10 | 0078-0813-01 |
NDC Item | 00078081301 |
Packaging | 3.5 g in 1 TUBE (0078-0813-01) |
FDA SPL set id | 861855 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1981-06-28 |
Marketing status | ACTIVE |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0078-0813 |
NDC Item 00247088181
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00247088181 |
Related queries | Properties for NDC 9 |
NDC Item 49999025935
NDC 9 | 49999-259 |
---|---|
NDC 10 | 49999-259-35 |
NDC Item | 49999025935 |
Related queries | Properties for NDC 9 49999-259 |
NDC Item 52959005101
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005101 |
Related queries | Properties for NDC 9 |
NDC Item 52959005103
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005103 |
Related queries | Properties for NDC 9 |
NDC Item 68071133505
NDC 9 | 68071-1335 |
---|---|
NDC 10 | 68071-1335-5 |
NDC Item | 68071133505 |
Related queries | Properties for NDC 9 68071-1335 |
NDC Item 00065064435
NDC 9 | 0065-0644 |
---|---|
NDC 10 | 0065-0644-35 |
NDC Item | 00065064435 |
Packaging | 3.5 g in 1 TUBE (0065-0644-35) |
FDA SPL set id | 691162 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-07-31 |
Marketing effective time low | 1981-06-28 |
Marketing status | COMPLETED |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0065-0644 |
NDC Item 00078081301
NDC 9 | 0078-0813 |
---|---|
NDC 10 | 0078-0813-01 |
NDC Item | 00078081301 |
Packaging | 3.5 g in 1 TUBE (0078-0813-01) |
FDA SPL set id | 861855 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1981-06-28 |
Marketing status | ACTIVE |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0078-0813 |
NDC Item 00247088181
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00247088181 |
Related queries | Properties for NDC 9 |
NDC Item 49999025935
NDC 9 | 49999-259 |
---|---|
NDC 10 | 49999-259-35 |
NDC Item | 49999025935 |
Related queries | Properties for NDC 9 49999-259 |
NDC Item 52959005101
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005101 |
Related queries | Properties for NDC 9 |
NDC Item 52959005103
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005103 |
Related queries | Properties for NDC 9 |
NDC Item 68071133505
NDC 9 | 68071-1335 |
---|---|
NDC 10 | 68071-1335-5 |
NDC Item | 68071133505 |
Related queries | Properties for NDC 9 68071-1335 |
NDC Item 00065064435
NDC 9 | 0065-0644 |
---|---|
NDC 10 | 0065-0644-35 |
NDC Item | 00065064435 |
Packaging | 3.5 g in 1 TUBE (0065-0644-35) |
FDA SPL set id | 691162 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-07-31 |
Marketing effective time low | 1981-06-28 |
Marketing status | COMPLETED |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0065-0644 |
NDC Item 00078081301
NDC 9 | 0078-0813 |
---|---|
NDC 10 | 0078-0813-01 |
NDC Item | 00078081301 |
Packaging | 3.5 g in 1 TUBE (0078-0813-01) |
FDA SPL set id | 861855 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1981-06-28 |
Marketing status | ACTIVE |
NDA | NDA050555 |
Related queries | Properties for NDC 9 0078-0813 |
NDC Item 00247088181
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00247088181 |
Related queries | Properties for NDC 9 |
NDC Item 49999025935
NDC 9 | 49999-259 |
---|---|
NDC 10 | 49999-259-35 |
NDC Item | 49999025935 |
Related queries | Properties for NDC 9 49999-259 |
NDC Item 52959005101
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005101 |
Related queries | Properties for NDC 9 |
NDC Item 52959005103
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959005103 |
Related queries | Properties for NDC 9 |
NDC Item 68071133505
NDC 9 | 68071-1335 |
---|---|
NDC 10 | 68071-1335-5 |
NDC Item | 68071133505 |
Related queries | Properties for NDC 9 68071-1335 |